Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect

NCT06058585 is registered in ClinicalTrials.gov with The George Institute as lead sponsor.

NCT NCT06058585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06058585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect
Lead sponsor
The George Institute
Phase
Phase 3
Overall status
Recruiting
Start date
September 4, 2024
Completion date
December 31, 2029
Enrollment
2,000 (estimated)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases